Literature DB >> 21637013

A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness.

Joel L N Barratt1, John Harkness, Deborah Marriott, John T Ellis, Damien Stark.   

Abstract

Dientamoeba fragilis is a protozoan that inhabits the human gut. It is approximately 100 years since Dientamoeba's discovery and first description when it was described as a rare and harmless commensal. Since then it has struggled to gain recognition as a pathogen despite the evidence supporting its pathogenicity. Dientamoeba remains neglected, probably due to the misconceptions that it is uncommon and non-pathogenic. Usually, carriage of Dientamoeba is associated with symptoms such as abdominal pain and diarrhea. Moreover, antimicrobial therapy followed by resolution of symptoms coincides with the eradication of Dientamoeba. This manuscript reviews the scientific literature relating to Dientamoeba's prevalence and pathogenicity. While much of the evidence supporting its pathogenicity is only circumstantial, it is apparent that most researchers agree that Dientamoeba is pathogenic. Therefore, in symptomatic patients who harbor Dientamoeba and no other pathogen, Dientamoeba should be considered as the etiological agent and treated as such.
© 2011 Landes Bioscience

Entities:  

Mesh:

Year:  2011        PMID: 21637013     DOI: 10.4161/gmic.2.1.14755

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  46 in total

Review 1.  Dientamoeba fragilis, One of the Neglected Intestinal Protozoa.

Authors:  Lynne S Garcia
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

2.  History of antimicrobial use and the risk of Dientamoeba fragilis infection.

Authors:  D Röser; J Simonsen; H V Nielsen; C R Stensvold; K Mølbak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-07       Impact factor: 3.267

3.  ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison.

Authors:  David Dunwell
Journal:  Br J Gen Pract       Date:  2013-02       Impact factor: 5.386

Review 4.  The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis.

Authors:  Ali Rostami; Seyed Mohammad Riahi; Ali Haghighi; Vafa Saber; Bahram Armon; Seyyed Javad Seyyedtabaei
Journal:  Parasitol Res       Date:  2017-07-01       Impact factor: 2.289

Review 5.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

6.  Diarrhea etiology in a pediatric emergency department: a case control study.

Authors:  Donna M Denno; Nurmohammad Shaikh; Jenny R Stapp; Xuan Qin; Carolyn M Hutter; Valerie Hoffman; Jody C Mooney; Kelly M Wood; Harold J Stevens; Robert Jones; Phillip I Tarr; Eileen J Klein
Journal:  Clin Infect Dis       Date:  2012-06-14       Impact factor: 9.079

7.  Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

Authors:  Anne Line Engsbro; C Rune Stensvold; Henrik V Nielsen; Peter Bytzer
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

8.  Description of Dientamoeba fragilis cyst and precystic forms from human samples.

Authors:  D Stark; L S Garcia; J L N Barratt; O Phillips; T Roberts; D Marriott; J Harkness; J T Ellis
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

Review 9.  Detection of intestinal protozoa in the clinical laboratory.

Authors:  Ian H McHardy; Max Wu; Robyn Shimizu-Cohen; Marc Roger Couturier; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

10.  Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR.

Authors:  D Röser; J Simonsen; H V Nielsen; C R Stensvold; K Mølbak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-24       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.